Applied Genetic Technologies Corporation (AGTC): Price and Financial Metrics
AGTC Price/Volume Stats
| Current price | $0.39 | 52-week high | $2.83 |
| Prev. close | $0.39 | 52-week low | $0.23 |
| Day low | $0.37 | Volume | 764,500 |
| Day high | $0.40 | Avg. volume | 943,490 |
| 50-day MA | $0.33 | Dividend yield | N/A |
| 200-day MA | $0.76 | Market Cap | 26.62M |
AGTC Stock Price Chart Interactive Chart >
Applied Genetic Technologies Corporation (AGTC) Company Bio
Applied Genetic Technologies is a clinical-stage biotechnology company that uses its proprietary gene therapy platform to develop products designed for patients with severe diseases in ophthalmology. The company was founded in 1999 and is based in Alachua, Florida.
Latest AGTC News From Around the Web
Below are the latest news stories about APPLIED GENETIC TECHNOLOGIES CORP that investors may wish to consider to help them evaluate AGTC as an investment opportunity.
Syncona Limited Portfolio Company Successfully Completes Tender Offer and Acquisition of Applied Genetic Technologies CorporationGAINESVILLE, Fla. and CAMBRIDGE, Mass., Dec. 01, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today the successful completion of the previously announced tender offer (the “Offer”) to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”). The Offer, as extended, expired at 5:00 p.m., Eastern Time, on November 30, 2022, and the acquisition |
Syncona Limited Portfolio Company Extends Tender Offer to Acquire Applied Genetic Technologies CorporationGAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (“AGTC” or the “Company”) (Nasdaq: AGTC), announced today that a portfolio company of Syncona Limited (LON: SYNC) (“Syncona”) has extended the expiration of its previously announced tender offer to purchase all of the issued and outstanding shares of AGTC common stock for $0.34 per share in cash at closing, plus up to an additional $0.73 per share payable pursuant to contingent valu |
*FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER*GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 28, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement of speci |
*REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *REMINDER*GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 22, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, reminds AGTC stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achievement of speci |
Applied Genetic Technologies Corporation Urges Shareholders to Tender Their Shares by November 28, 2022GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 14, 2022 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), President and Chief Executive Officer, Sue Washer, sent the following letter to stockholders: A Syncona Limited portfolio company has commenced a tender offer to purchase all outstanding shares of AGTC common stock at a price per share of $0.34 in cash plus the right for AGTC stockholders to receive additional aggregate payments of up to $0.73 per share upon the achi |
AGTC Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | 47.11% |
| 3-year | -92.07% |
| 5-year | -94.36% |
| YTD | N/A |
| 2022 | 0.00% |
| 2021 | -53.55% |
| 2020 | -9.51% |
| 2019 | 81.53% |
| 2018 | -30.83% |
Continue Researching AGTC
Want to see what other sources are saying about Applied Genetic Technologies Corp's financials and stock price? Try the links below:Applied Genetic Technologies Corp (AGTC) Stock Price | Nasdaq
Applied Genetic Technologies Corp (AGTC) Stock Quote, History and News - Yahoo Finance
Applied Genetic Technologies Corp (AGTC) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...